Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 79
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
World J Urol ; 42(1): 248, 2024 Apr 22.
Artículo en Inglés | MEDLINE | ID: mdl-38647689

RESUMEN

PURPOSE: Although targeted biopsies (TBx) are associated with improved disease assessment, concerns have been raised regarding the risk of prostate cancer (PCa) overgrading due to more accurate biopsy core deployment in the index lesion. METHODS: We identified 1672 patients treated with radical prostatectomy (RP) with a positive mpMRI and ISUP ≥ 2 PCa detected via systematic biopsy (SBx) plus TBx. We compared downgrading rates at RP (ISUP 4-5, 3, and 2 at biopsy, to a lower ISUP) for PCa detected via SBx only (group 1), via TBx only (group 2), and eventually for PCa detected with the same ISUP 2-5 at both SBx and TBx (group 3), using multivariable logistic regression models (MVA). RESULTS: Overall, 12 vs 14 vs 6% (n = 176 vs 227 vs 96) downgrading rates were recorded in group 1 vs group 2 vs group 3, respectively (p < 0.001). At MVA, group 2 was more likely to be downgraded (OR 1.26, p = 0.04), as compared to group 1. Conversely, group 3 was less likely to be downgraded at RP (OR 0.42, p < 0.001). CONCLUSIONS: Downgrading rates are highest when PCa is present in TBx only and, especially when the highest grade PCa is diagnosed by TBx cores only. Conversely, downgrading rates are lowest when PCa is identified with the same ISUP through both SBx and TBx. The presence of clinically significant disease at SBx + TBx may indicate a more reliable assessment of the disease at the time of biopsy potentially reducing the risk of downgrading at final pathology.


Asunto(s)
Imágenes de Resonancia Magnética Multiparamétrica , Neoplasias de la Próstata , Humanos , Neoplasias de la Próstata/patología , Neoplasias de la Próstata/cirugía , Masculino , Persona de Mediana Edad , Anciano , Biopsia Guiada por Imagen/métodos , Clasificación del Tumor , Prostatectomía/métodos , Estudios Retrospectivos , Medición de Riesgo , Próstata/patología , Biopsia/métodos
3.
Reprod Domest Anim ; 50(6): 918-25, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26392300

RESUMEN

Experiments were devised to characterize the expression of nerve growth factor, beta polypeptide (NGF), and its cognate receptors neurotrophic tyrosine kinase receptor type 1 (NTRK1) and nerve growth factor receptor (NGFR) in rabbit male sex organs, as well as the concentrations of NGF in both seminal and blood plasma of sexually mature male rabbits. Immunoreactivity and gene expression for NGF and cognate receptors were detected in testis, prostate gland and seminal vesicle. The highest levels of NGF and NTRK1 transcripts were found in the prostate, while intermediate expressions were found in the testis. NGFR transcripts were expressed at the same levels in both testis and prostate and were more abundant than in seminal vesicles. The widespread distribution of NGF in all prostate glandular cells, together with its relative high mRNA abundance, confirms that the prostate of rabbits is the main source of this neurotrophin. In conclusion, the present data suggest that the NGF system is involved in the testicular development and spermatogenesis of rabbits and that NGF may act as a potential ovulation-inducing factor being abundantly present in the seminal plasma.


Asunto(s)
Factor de Crecimiento Nervioso/genética , ARN Mensajero/genética , Conejos/genética , Receptor trkA/genética , Receptores de Factor de Crecimiento Nervioso/genética , Animales , Células Epiteliales/metabolismo , Expresión Génica , Masculino , Próstata/metabolismo , Testículo/metabolismo
5.
Hernia ; 23(3): 569-581, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30570686

RESUMEN

PURPOSE: Patients who undergo inguinal hernioplasty may suffer from persistent postoperative pain due to inguinal nerve injuries. The aim of this systematic review and meta-analysis was to provide comprehensive data on the prevalence (identification rates), anatomical characteristics, and ethnic variations of the ilioinguinal (IIN), the iliohypogastric (IHN) and the genital branch of the genitofemoral (GNF) nerves. METHODS: The systematic literature search was conducted using the PubMed, Scopus and Web of Science databases. RESULTS: A total of 26 articles (5265 half-body examinations) were included in this study. The identification rate of the IIN was 94.4% (95% CI 89.5-97.9) using a random-effects model. Unweighted multiple regression analysis showed that study sample size (ß = - 0.74, p = .036) was the only statistically significant predictor of lower prevalence. The identification rates of the IHN and GNF was 86.7% (95% CI 78.3%-93.3%) and 69.1% (95% CI 53.1%-83.0%) using a random-effects model, respectively. For those outcomes, a visual analysis of funnel and Doi plots indicated irregularity and provided evidence that larger studies tended to have lower identification rates. In terms of the synthesis of anatomical reference points, there was a large and statistically significant amount of heterogeneity for most outcomes. CONCLUSIONS: The identification rates of the inguinal nerves in our study were lower than reported in literature. The lowest was found for GNF, suggesting that this nerve was the most difficult to identify. Knowledge regarding the anatomy of the inguinal nerves can facilitate their proper identification and reduce the risk of iatrogenic injury and postoperative pain.


Asunto(s)
Ingle/inervación , Hernia Inguinal/cirugía , Herniorrafia/métodos , Plexo Lumbosacro/cirugía , Cadáver , Ingle/anatomía & histología , Ingle/cirugía , Herniorrafia/efectos adversos , Humanos , Plexo Lumbosacro/anatomía & histología , Plexo Lumbosacro/lesiones , Masculino , Traumatismos de los Nervios Periféricos/etiología , Traumatismos de los Nervios Periféricos/prevención & control
6.
Regul Pept ; 147(1-3): 67-71, 2008 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-18243366

RESUMEN

The present study was designed to assess the hypothesis that dexamethasone (DEX) through the control of nitric oxide (NO) synthesis could regulate the release of vasopressin (AVP), which plays an important role in the regulation of arterial pressure and plasma osmolality. Endotoxemic shock was induced by intravenous (i.v.) injection of 1.5 mg/kg lipopolisaccharide (LPS) in male Wistar rats weighing 250-300 g. After LPS administration, a group of animals were treated with DEX (1.0 mg/kg of body weight), whereas saline-injected rats served as controls. The LPS administration induced a significant decrease in mean arterial pressure (MAP) with a concomitant increase in heart rate (HR) (Delta VMAP: -16.1+/-4.2 mm Hg; Delta VHR: 47.3+/-8.1 bpm). An increase in plasma AVP concentration occurred and was present for 2 h after LPS administration (11.1+/-0.9 pg/mL) returning close to basal levels thereafter and remaining unchanged until the end of the experiment. When LPS was combined with i.v. administration of a low dose of DEX, we observed an attenuation in the drop of MAP (Delta VMAP: -2.2+/-1.9 mm Hg) and a decrease in NO plasma concentration [NO] after LPS administration (1098.1+/-68.1 microM) compared to [NO] after DEX administration (523.4+/-75.2 microM). However, this attenuation in the drop of MAP was accompanied by a decrease in AVP plasma concentration (3.7+/-0.4 pg/mL). These data suggest that AVP does not participate in the recovery of MAP when DEX is administered in this endotoxemic shock model.


Asunto(s)
Dexametasona/farmacología , Glucocorticoides/farmacología , Choque Séptico/metabolismo , Vasopresinas/metabolismo , Animales , Presión Sanguínea/efectos de los fármacos , Lipopolisacáridos/farmacología , Masculino , Óxido Nítrico/biosíntesis , Ratas , Ratas Wistar , Choque Séptico/complicaciones
7.
Eur Rev Med Pharmacol Sci ; 12(1): 47-53, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18401972

RESUMEN

Anti-phospholipid syndrome (APS) is a potentially life-threatening autoimmune condition characterized by the presence of anti-phospholipid antibodies (aPL) giving rise to increased hypercoagulability, which induces venous or arterial thrombotic events at whatever age and recurrent fetal loss in the fertile age. Antigens that are targeted by aPL include cardiolipin and beta2-glycoprotein I. Primary APS is defined in the absence of an underlying disease, while secondary APS is observed in the context of another established pathological condition. APS has a wide variety of clinical signs and serological characteristics. This paper describes the current approaches towards diagnosis, therapeutic modalities and secondary prevention applied to children.


Asunto(s)
Anticuerpos Antifosfolípidos/inmunología , Síndrome Antifosfolípido/tratamiento farmacológico , Síndrome Antifosfolípido/fisiopatología , Síndrome Antifosfolípido/diagnóstico , Cardiolipinas/inmunología , Niño , Humanos , Índice de Severidad de la Enfermedad , Trombosis/etiología , beta 2 Glicoproteína I/inmunología
8.
Toxicol In Vitro ; 53: 29-36, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30076938

RESUMEN

Long-term exposure to cigarette smoke induces severe injuries to respiratory system through several mechanisms, some of them are well defined, but many others are not yet elucidated. Beside its classical role in nervous system, we have previously shown that Nerve Growth Factor (NGF) and its receptors have a crucial role in airway inflammatory diseases, such as Chronic Obstructive Pulmonary Disease. To expand our knowledge about the relevance of NGF and its receptors in airway diseases induced by cigarette smoking, we exposed for 16 weeks the bronchial epithelial cell line BEAS-2B to sub-toxic concentrations of whole cigarette smoke extract or pure nicotine. Viability, cell cycle gene expression, cell morphology and migration ability were tested and compared to NGF release and gene expression. Modulation of its receptors TrKA and p75NTR was also analyzed. The present study shows that long term exposure of BEAS-2B cells to cigarette smoke extract or nicotine induces: (A) differences: in cell viability, in the expression of cell cycle-related genes, in NGF release and in gene expression of NGF and its receptors; (B) similarities: in morphology and migration ability. Taken together, our data provide new insights about the biological role of NGF and its receptors in airway diseases induced by long-term cigarette smoking and, finally, our data evidence the opportunity not to use nicotine lozenges or e-cigarettes as anti smoking replacement therapy in patients with a previous airway disease according to the ability of nicotine to increase the amount of the pro-inflammatory cytokine NGF into the bronchial environment.


Asunto(s)
Células Epiteliales/efectos de los fármacos , Factor de Crecimiento Nervioso/genética , Nicotina/toxicidad , Humo/efectos adversos , Productos de Tabaco , Bronquios/citología , Línea Celular , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Epiteliales/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Proteínas del Tejido Nervioso/genética , Receptor trkA/genética , Receptores de Factor de Crecimiento Nervioso/genética , Proteína p53 Supresora de Tumor/genética
9.
Andrology ; 6(1): 136-141, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29195014

RESUMEN

Neglected side effects after radical prostatectomy have been previously reported. In this context, the prevalence of penile morphometric alterations has never been assessed in robot-assisted radical prostatectomy series. We aimed to assess prevalence of and predictors of penile morphometric alterations (i.e. penile shortening or penile morphometric deformation) at long-term follow-up in patients submitted to either robot-assisted (robot-assisted radical prostatectomy) or open radical prostatectomy. Sexually active patients after either robot-assisted radical prostatectomy or open radical prostatectomy prospectively completed a 28-item questionnaire, with sensitive issues regarding sexual function, namely orgasmic functioning, climacturia and changes in morphometric characteristics of the penis. Only patients with a post-operative follow-up ≥ 24 months were included. Patients submitted to either adjuvant or salvage therapies or those who refused to comprehensively complete the questionnaire were excluded from the analyses. A propensity-score matching analysis was implemented to control for baseline differences between groups. Logistic regression models tested potential predictors of penile morphometric alterations at long-term post-operative follow-up. Overall, 67 (50%) and 67 (50%) patients were included after open radical prostatectomy or robot-assisted radical prostatectomy, respectively. Self-rated post-operative penile shortening and penile morphometric deformation were reported by 75 (56%) and 29 (22.8%) patients, respectively. Rates of penile shortening and penile morphometric deformation were not different after open radical prostatectomy and robot-assisted radical prostatectomy [all p > 0.5]. At univariable analysis, self-reported penile morphometric alterations (either penile shortening or penile morphometric deformation) were significantly associated with baseline international index of erectile function-erectile function scores, body mass index, post-operative erectile function recovery, year of surgery and type of surgery (all p < 0.05). At multivariable analysis, robot-assisted radical prostatectomy was independently associated with a lower risk of post-operative penile morphometric alterations (OR: 0.38; 95% CI: 0.16-0.93). Self-perceived penile morphometric alterations were reported in one of two patients after radical prostatectomy at long-term follow-up, with open surgery associated with a potential higher risk of this self-perception.


Asunto(s)
Efectos Adversos a Largo Plazo/patología , Pene/patología , Complicaciones Posoperatorias/patología , Prostatectomía/efectos adversos , Prostatectomía/métodos , Anciano , Humanos , Efectos Adversos a Largo Plazo/epidemiología , Efectos Adversos a Largo Plazo/etiología , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Procedimientos Quirúrgicos Robotizados/efectos adversos
10.
Theriogenology ; 105: 61-65, 2018 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-28923707

RESUMEN

The addition of aminopeptidase inhibitors (AMIs) to rabbit semen extenders could be a solution to decrease the hormone degradation (GnRH) by the aminopeptidases existing in the seminal plasma. Therefore, the quantity of GnRH needed to induce ovulation in doe would be comparable with the amount administered intramuscularly (i.m.). This study was conducted to evaluate the effects of two AMIs (bestatin and EDTA) on rabbit semen quality parameters, ß nerve growth factor (ß-NGF) degradation and reproductive performance after artificial insemination. Results showed that seminal quality was not affected by the incubation with AMIs; the values of motility, acrosome integrity and sperm viability were not significantly different between the AMIs and the control groups (positive i.m. and negative intravaginally without AMIs). In addition, the aminopeptidase activity of seminal plasma was inhibited in a 55.5% by the AMIs as well as ß-NGF degradation. On the other hand, regarding the effect of AMIs on reproductive performance, our results showed that the presence of bestatin and EDTA did neither affect fertility (85.3 vs. 88.6%), nor the prolificacy rate (10.12 vs. 10.51 kits per delivery), comparing AMIs group to positive control group, respectively. We conclude that the addition of specific AMIs in the rabbit semen extender has no effect on reproductive performance. Therefore, due to the fact that AMIs inhibit part of the aminopeptidase activity that degrades the GnRH analogue and ß-NGF, they could be used to develop new extenders with less hormone concentration.


Asunto(s)
Ácido Edético/farmacología , Inseminación Artificial/veterinaria , Leucina/análogos & derivados , Conejos/fisiología , Preservación de Semen/veterinaria , Animales , Ácido Edético/administración & dosificación , Femenino , Fertilidad/efectos de los fármacos , Leucina/administración & dosificación , Leucina/farmacología , Masculino , Embarazo , Semen/efectos de los fármacos , Análisis de Semen , Motilidad Espermática/efectos de los fármacos , Espermatozoides/fisiología
11.
Rheumatol Int ; 28(1): 73-6, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17564712

RESUMEN

Unilateral cervical mass and fever were firstly misdiagnosed as bacterial lymphadenitis in a 6-year-old child and empirically treated with antibiotics. Later the child developed the additional features of Kawasaki syndrome and received intravenous immunoglobulins at the eighth day since fever onset with progressive disappearance of the cervical mass and no cardiac sequel. Kawasaki syndrome should be considered in childhood as a relevant cause of cervical lymphadenopathy unresponding to antibiotics: its recognition at an early stage might contribute to anticipate a proper treatment and abate heart complication rate.


Asunto(s)
Errores Diagnósticos , Linfadenitis/diagnóstico , Síndrome Mucocutáneo Linfonodular/diagnóstico , Niño , Diagnóstico Diferencial , Humanos , Masculino , Síndrome Mucocutáneo Linfonodular/diagnóstico por imagen , Ultrasonografía
12.
Ann Ig ; 19(4): 303-14, 2007.
Artículo en Italiano | MEDLINE | ID: mdl-17937323

RESUMEN

Administration of prohibited substances to enhance athletic performance represents an emerging medical, social, ethical and legal issue. Traditional controls are based on direct detection of substances or their catabolites. However out-of-competition doping may not be easily revealed by standard analytical methods. Alternative indirect control strategies are based on the evaluation of mid- and long-term effects of doping in tissues. Drug-induced long-lasting changes of gene expression may be taken as effective indicators of doping exposure. To validate this approach, we used real-time PCR to monitor the expression pattern of selected genes in human haematopoietic cells exposed to nandrolone, insulin-like growth factor I (IGF-I) or growth hormone (GH). Some candidate genes were found significantly and consistently modulated by treatments. Nandrolone up-regulated AR, ESR2 and PGR in K562 cells, and SRD5A1, PPARA and JAK2 in Jurkat cells; IGF-I up-regulated EPOR and PGR in HL60 cells, and SRD5A1 in Jurkat; GH up-regulated SRD5A1 and GHR in K562. GATA1 expression was down-regulated in IGF-1-treated HL60, ESR2 was down-regulated in nandrolone-treated Jurkat, and AR and PGR were down-regulated in GH-treated Jurkat. This pilot study shows the potential of molecular biology-based strategies in anti-doping controls.


Asunto(s)
Anabolizantes/farmacología , Doping en los Deportes , Marcadores Genéticos/efectos de los fármacos , Células Madre Hematopoyéticas/metabolismo , Hormona de Crecimiento Humana/farmacología , Factor I del Crecimiento Similar a la Insulina/farmacología , Nandrolona/farmacología , Detección de Abuso de Sustancias/métodos , Anabolizantes/administración & dosificación , Células Cultivadas , Regulación hacia Abajo/efectos de los fármacos , Quimioterapia Combinada , Células HL-60 , Células Madre Hematopoyéticas/efectos de los fármacos , Hormona de Crecimiento Humana/administración & dosificación , Humanos , Factor I del Crecimiento Similar a la Insulina/administración & dosificación , Italia , Células Jurkat , Células K562 , Nandrolona/administración & dosificación , Proyectos Piloto , Reacción en Cadena de la Polimerasa/métodos , Estudios Prospectivos , Reproducibilidad de los Resultados , Detección de Abuso de Sustancias/estadística & datos numéricos , Regulación hacia Arriba/efectos de los fármacos
13.
Intensive Crit Care Nurs ; 41: 98-103, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28318952

RESUMEN

BACKGROUND: Sepsis is associated with morbidity and mortality, which implies high costs to the global health system. Metabolic alterations that increase glycaemia and glycaemic variability occur during sepsis. OBJECTIVE: To verify mean body glucose levels and glycaemic variability in Intensive Care Unit (ICU) patients with severe sepsis or septic shock. METHOD: Retrospective and exploratory study that involved collection of patients' sociodemographic and clinical data and calculation of severity scores. Glycaemia measurements helped to determine glycaemic variability through standard deviation and mean amplitude of glycaemic excursions. RESULTS: Analysis of 116 medical charts and 6730 glycaemia measurements revealed that the majority of patients were male and aged over 60 years. Surgical treatment was the main reason for ICU admission. High blood pressure and diabetes mellitus were the most usual comorbidities. Patients that died during the ICU stay presented the highest SOFA scores and mean glycaemia; they also experienced more hypoglycaemia events. Patients with diabetes had higher mean glycaemia, evaluated through standard deviation and mean amplitude of glycaemia excursions. CONCLUSION: Organic impairment at ICU admission may underlie glycaemic variability and lead to a less favourable outcome. High glycaemic variability in patients with diabetes indicates that monitoring of these individuals is crucial to ensure better outcomes.


Asunto(s)
Glucemia/análisis , Sepsis/fisiopatología , Choque Séptico/fisiopatología , Adulto , Anciano , Distribución de Chi-Cuadrado , Complicaciones de la Diabetes/diagnóstico , Complicaciones de la Diabetes/enfermería , Diabetes Mellitus/enfermería , Diabetes Mellitus/fisiopatología , Femenino , Humanos , Hiperglucemia/diagnóstico , Hiperglucemia/enfermería , Unidades de Cuidados Intensivos/organización & administración , Unidades de Cuidados Intensivos/estadística & datos numéricos , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Curva ROC , Estudios Retrospectivos , Sepsis/mortalidad , Índice de Severidad de la Enfermedad , Choque Séptico/mortalidad , Encuestas y Cuestionarios
14.
Eur Rev Med Pharmacol Sci ; 10(3): 107-10, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16875042

RESUMEN

Rheumatic heart disease is still a relevant problem in children, adolescents and young adults. Molecular mimicry between streptococcal and human proteins has been proposed as the triggering factor leading to autoimmunity and tissue damage in rheumatic heart disease. Despite the widespread application of Jones' criteria, carditis is either underdiagnosed or overdiagnosed. Endocarditis leading to mitral and/or aortic regurgitation influences morbidity and mortality of rheumatic heart disease, whilst myocarditis and pericarditis are less significant in determining adverse outcomes in the long-term. Strategy available for disease control remains mainly secondary prophylaxis with the long-acting penicillin G-benzathine.


Asunto(s)
Antibacterianos/uso terapéutico , Antiinflamatorios/uso terapéutico , Cardiotónicos/uso terapéutico , Endocarditis Bacteriana/prevención & control , Cardiopatía Reumática/tratamiento farmacológico , Infecciones Estreptocócicas/prevención & control , Adolescente , Cefalosporinas/uso terapéutico , Niño , Digoxina/uso terapéutico , Endocarditis Bacteriana/tratamiento farmacológico , Endocarditis Bacteriana/etiología , Humanos , Miocarditis/tratamiento farmacológico , Miocarditis/etiología , Miocarditis/prevención & control , Penicilina G/uso terapéutico , Pericarditis/tratamiento farmacológico , Pericarditis/etiología , Pericarditis/prevención & control , Guías de Práctica Clínica como Asunto , Prednisona/uso terapéutico , Cardiopatía Reumática/etiología , Cardiopatía Reumática/prevención & control , Salicilatos/uso terapéutico , Prevención Secundaria , Infecciones Estreptocócicas/complicaciones , Factores de Tiempo
15.
Eur Rev Med Pharmacol Sci ; 10(5): 229-34, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17121315

RESUMEN

OBJECTIVE: To classify a cohort of Italian patients categorized as affected with juvenile idiopathic arthritis (JIA) according to the revised 2001 Edmonton International League of Associations for Rheumatology (ILAR) criteria. METHODS: Eighty-five patients with JIA firstly framed depending on traditional criteria during the last ten years were reallocated according to the JIA revised criteria proposed in 2001 by ILAR in Edmonton. RESULTS: The revision consented to define the following distribution of patients: 28.2% systemic, 55.3% oligoarticular and 11.8% polyarticular forms; only one child was defined as having psoriatic arthritis, one child with enthesitis-associated arthritis and two with the undifferentiated form of JIA. DISCUSSION: The 97.6% of the recruited patients were strictly classified according to the Edmonton ILAR criteria, demonstrating a very low number of patients whose arthritis could not be assigned to any JIA category due to unfulfillment of the required criteria.


Asunto(s)
Artritis Juvenil/clasificación , Niño , Preescolar , Estudios de Cohortes , Femenino , Humanos , Lactante , Italia , Masculino , Reumatología , Sociedades Médicas
16.
Eur Rev Med Pharmacol Sci ; 10(4): 163-71, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16910345

RESUMEN

Familial Mediterranean fever (FMF) is characterized by recurrent self-limiting flares of fever in the absence of pathogens, autoantibodies or antigen specific T cells and is inherited as an autosomal recessive trait probably deriving from common ancestors of Armenian, Jew, Turk and Arab origin. The underlying pathogenetic mechanisms of FMF have not been fully interpreted, but mutations in the gene MEFV encoding pyrin, a natural repressor of proinflammatory molecules, result in uncontrolled relapsing systemic inflammation, increased leukocyte migration to serosal membranes or joints and inappropriate response to inflammatory stimuli. FMF heterogeneous phenotypic expression could originate both from allelic heterogeneity or from the existence of modulating genes. Proper diagnosis of FMF is needed to begin both specific clinical management and treatment based on continuous prophylactic administration of colchicine, preventing flares or at least the onset of amyloidosis.


Asunto(s)
Fiebre Mediterránea Familiar/diagnóstico , Fiebre Mediterránea Familiar/tratamiento farmacológico , Periodicidad , Amiloidosis/prevención & control , Antiinflamatorios/uso terapéutico , Niño , Colchicina/uso terapéutico , Proteínas del Citoesqueleto/genética , Diagnóstico Diferencial , Fiebre Mediterránea Familiar/epidemiología , Fiebre Mediterránea Familiar/genética , Genotipo , Humanos , Mutación , Pirina , Calidad de Vida
17.
Eur Rev Med Pharmacol Sci ; 10(4): 173-8, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16910346

RESUMEN

Familial Mediterranean fever (FMF) is the prototype of auto-inflammatory disorders and is ethnically restricted to people living in the Mediterranean basin and Middle-East. Pyrin, the protein product of the FMF gene, expressed in myeloid cells and fibroblasts, interacts with the cytoskeletal machinery and may modulate leukocyte effector functions. At present colchicine, an alkaloid with antimitotic activity interfering with microtubule formation, which has been used to alleviate acute gout, is the only available drug for patients with FMF to prevent both acute attacks and long-term complications such as amyloidosis. The anti-inflammatory effect of colchicine may be mediated not only through direct interaction with microtubules, but also through changes at the transcriptional level influencing cell cycle regulation and leukocyte migration. Gastrointestinal side effects may occur early and are the most frequent manifestations of colchicine toxicity in children, whilst multiple organ failure is very rarely reported as overdosage expression.


Asunto(s)
Antiinflamatorios/farmacología , Colchicina/farmacología , Fiebre Mediterránea Familiar/tratamiento farmacológico , Periodicidad , Amiloidosis/prevención & control , Antiinflamatorios/administración & dosificación , Antiinflamatorios/efectos adversos , Antiinflamatorios/farmacocinética , Niño , Preescolar , Colchicina/administración & dosificación , Colchicina/efectos adversos , Colchicina/farmacocinética , Proteínas del Citoesqueleto/genética , Interacciones Farmacológicas , Monitoreo de Drogas , Etnicidad/genética , Fiebre Mediterránea Familiar/genética , Fiebre Mediterránea Familiar/prevención & control , Humanos , Enfermedades Renales/prevención & control , Mutación , Pirina
18.
Eur Rev Med Pharmacol Sci ; 10(2): 53-9, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16705949

RESUMEN

Macrophage activation syndrome is a rare and potentially fatal complication of many childhood pathological settings, most frequently reported in systemic onset-juvenile idiopathic arthritis. The disruption of the macrophage-lymphocyte interaction leads to uncontrolled proliferation of highly activated macrophages and T lymphocytes. The syndrome comprises a heterogeneous group of disorders featuring sepsis-like characteristics typically combined with impaired function of natural killer cells and cytotoxic T-cells, haemophagocytosis and hypercytokinemia, often resulting in fatal multiple organ failure. The clinical picture shows high grade fever, hepatosplenomegaly, pancytopenia, lymphoadenopathy, central nervous system involvement and consumptive coagulopathy. Macrophage activation syndrome is associated with high mortality: even though diagnostic criteria have been proposed, definite diagnosis can be a challenge for clinicians, especially in early phases. There is no standardized therapeutic protocol for macrophage activation syndrome, but it is widely recognized that aggressive treatment strategies might strongly influence prognosis. First line-therapy is usually represented by parenteral administration of high dose-corticosteroids, whilst cyclosporine is added in the steroid-resistant cases. In this paper we provide clinical clues and summarize the most recent studies about pathophysiology and management suggestions for macrophage activation syndrome.


Asunto(s)
Antiinflamatorios/uso terapéutico , Ciclosporina/uso terapéutico , Inmunosupresores/uso terapéutico , Linfohistiocitosis Hemofagocítica/terapia , Activación de Macrófagos/efectos de los fármacos , Metilprednisolona/uso terapéutico , Adolescente , Antiinflamatorios/administración & dosificación , Artritis Juvenil/complicaciones , Niño , Quimioterapia Combinada , Humanos , Lactante , Infusiones Intravenosas , Linfohistiocitosis Hemofagocítica/etiología , Linfohistiocitosis Hemofagocítica/genética , Linfohistiocitosis Hemofagocítica/patología , Glicoproteínas de Membrana/genética , Metilprednisolona/administración & dosificación , Perforina , Proteínas Citotóxicas Formadoras de Poros , Síndrome
19.
J Neuroendocrinol ; 28(6)2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-27037598

RESUMEN

Besides their well-established endocrine roles, vasopressin and oxytocin are also important regulators of immune function, participating in a complex neuroendocrine-immune network. In the present study, we investigated whether and how vasopressin and oxytocin could modulate lipopolysaccharide (LPS)-induced nitric oxide (NO) production in a well-established model of experimental endotoxaemia. Male Wistar rats were previously treated i.v. with vasopressin V1 or oxytocin receptor antagonists and then received either an i.v. LPS injection to induce endotoxaemia or a saline imjection as a control. The animals were divided into two groups: in the first group, blood was collected at 2, 4 and 6 h after LPS injection; in the second group, mean arterial blood pressure (MABP) and heart rate (HR) were recorded over 6 h. Plasma vasopressin and oxytocin values were higher in LPS- compared to saline-injected animals at 2 and 4 h but returned to basal levels at 6 h. NO levels exhibited an opposite pattern, showing a progressive increase over the entire period. The previous administration of a vasopressin V1 receptor antagonist significantly reduced NO plasma concentrations at 2 and 4 h but not at 6 h. By contrast, oxytocin receptor agonist pre-treatment had no effect on the NO plasma concentration. In relation to MABP, previous treatment with vasopressin V1 receptor antagonist reversed the LPS-induced hypotension at 4 h, although this was not the case for oxytocin antagonist-treated animals. None of the antagonists affected HR. Our findings indicate that vasopressin (but not oxytocin) has effects on NO production during endotoxaemia in rats, although they do not lend support to the proposed anti-inflammatory actions of vasopressin during endotoxaemia.


Asunto(s)
Endotoxemia/sangre , Hipotensión/sangre , Óxido Nítrico/sangre , Oxitocina/sangre , Neurohipófisis/metabolismo , Vasopresinas/sangre , Animales , Antagonistas de los Receptores de Hormonas Antidiuréticas/farmacología , Arginina Vasopresina/análogos & derivados , Arginina Vasopresina/farmacología , Presión Sanguínea/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Hipotensión/inducido químicamente , Lipopolisacáridos/antagonistas & inhibidores , Masculino , Ratas , Receptores de Oxitocina/antagonistas & inhibidores , Factores de Tiempo
20.
Chest ; 95(1): 124-9, 1989 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2642405

RESUMEN

We report our prospective experience with sensitivity, specificity, predictive values and efficiency of echocardiography in diagnosing AD involving the ascending aorta (type A). We studied two groups of patients with both echocardiography and aortography. Group 1 was made up by 46 consecutive patients with clinical suspicion of AD. Type A AD was confirmed in 23 cases. Group 2 was comprised of 509 adult patients who had been studied during the same period with both aortography and echocardiography (including 46 patients from group 1); prevalence of type A AD in this group was 4.9 percent. We conclude that the diagnostic usefulness of echocardiography in patients with suspected type A AD is limited by its moderate sensitivity and predictive positive value. Aortography remains the major step in diagnosis. Within these limitations, echocardiography is useful in confirmation of clinical suspicion if all three main echocardiographic signs are present (predictive positive value: 100 percent).


Asunto(s)
Aneurisma de la Aorta/diagnóstico , Disección Aórtica/diagnóstico , Ecocardiografía , Adulto , Anciano , Anciano de 80 o más Años , Disección Aórtica/diagnóstico por imagen , Aneurisma de la Aorta/diagnóstico por imagen , Aortografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Prospectivos , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA